Back to search
FDAFDA · Food and drugs·Recall number Z-0705-2022

Everest MI XT Inner Dilator, Catalog Number 5101-90167

Published March 9, 2022 · Recall initiated: January 13, 2022

Summary

FDA records medical device Class II recall Z-0705-2022, published March 9, 2022 and initiated January 13, 2022. Recalling firm: K2M, Inc; Status: Ongoing; Reported quantity: 686 Total Devices; Lot: GTIN: 10888857261204; Lot Numbers: JUJF KFMV KUPG KYYU MDRB NDMK NDMX NXJK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stryker received two (2) complaints for units from specific lots of Inner and Outer Dilators not fitting together properly during a surgical procedure. Some dilators from these lots and from other lots were subsequently determined to be affected by a manufacturing nonconformance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
K2M, Inc
Distributor
Worldwide distribution - US Nationwide.
Lot
GTIN: 10888857261204; Lot Numbers: JUJF KFMV KUPG KYYU MDRB NDMK NDMX NXJK
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Everest MI XT Inner Dilator, Catalog Number 5101-90167 recalled?

Yes. FDA published recall Z-0705-2022 on March 9, 2022. Reported hazard: Stryker received two (2) complaints for units from specific lots of Inner and Outer Dilators not fitting together properly during a surgical procedure. Some dilators from these lots and from other lots were subsequently determined to be affected by a manufacturing nonconformance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter